Article info
PDFLate breaking abstracts
4CPS-178 Durability of treatment and reasons for discontinuation of dimethyl fumarate and teriflunomide in patients with multiple sclerosis
Citation
4CPS-178 Durability of treatment and reasons for discontinuation of dimethyl fumarate and teriflunomide in patients with multiple sclerosis
Publication history
- First published May 2, 2023.
Online issue publication
May 02, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.